BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
90.36
+2.57 (2.93%)
May 20, 2026, 4:00 PM EDT - Market closed

BioNTech SE Revenue

BioNTech SE had revenue of 148.50M EUR in the quarter ending March 31, 2026, a decrease of -39.24%. This brings the company's revenue in the last twelve months to 2.84B, up 0.99% year-over-year. In the year 2025, BioNTech SE had annual revenue of 3.05B with 5.63% growth.

Revenue (ttm)
2.84B EUR
Revenue Growth
+0.99%
P/S Ratio
7.06
Revenue / Employee
363,213 EUR
Employees
7,807
Market Cap
22.85B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20253.05B162.80M5.63%
Dec 31, 20242.89B-1.03B-26.31%
Dec 31, 20233.92B-13.39B-77.33%
Dec 31, 202217.31B-1.67B-8.78%
Dec 31, 202118.98B18.49B3,834.63%
Dec 31, 2020482.30M373.70M344.11%
Dec 31, 2019108.60M-18.98M-14.87%
Dec 31, 2018127.58M65.98M107.11%
Dec 31, 201761.60M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
BeOne Medicines AG5.70B
Incyte5.36B
Jazz Pharmaceuticals4.44B
Genmab3.90B
Royalty Pharma2.44B
Moderna2.23B
Ascendis Pharma998.25M
Insmed819.56M
Revenue Rankings